Matthew Resnick, M.D., MPH, MMHC is currently Assistant Professor of Urologic Surgery and Health Policy at Vanderbilt University Medical Center. He received his M.D. degree from the University of Pennsylvania where he completed his residency training. Dr. Resnick subsequently served as a clinical fellow in urologic oncology and a Veterans Affairs National Quality Scholar at Vanderbilt University, where he obtained Masters degrees in both public health and health care management. Dr. Resnick’s primary research program is focused on the relationship between of payment reform and appropriateness and intensity of cancer diagnosis, treatment, and survivorship. Dr. Resnick is actively investigating the implications of Medicare ACO enrollment on appropriateness of cancer screening to determine the net effect of financial incentives on the delivery of recommended and discretionary health care services. Additionally, he leads efforts at Vanderbilt to develop and implement strategies for longitudinal data linkage to support population health efforts both in the PCORI-funded Mid-South Clinical Data Research Network and the CMMI-funded Practice Transformation Network. In addition to his research and clinical responsibilities, Dr. Resnick is responsible for the development of operational innovations to support successful transition to risk-bearing payment models within the Department of Urologic Surgery and the Section of Surgical Sciences. He leads the development and implementation of telehealth within the Department of Urologic Surgery. He leads an effort to deploy real time locating system technology to optimize clinical processes and deliver real-time cost assessment within urologic surgery. Dr. Resnick maintains an active clinical practice in genitourinary oncology.